
















16TEVAR for traumatic thoracic injury with the first-generation
stent graftGiovanni Tinelli, MD, PhD,a Fabrizio Minelli, MD,a Simona Sica, MD,a Francesca De Nigris, MD,a
Massimo Massetti, MD,b and Yamume Tshomba, MD,a Rome, ItalyABSTRACT
Thoracic endovascular aortic repair (TEVAR) is a life-saving treatment for blunt thoracic aortic injury. We report long-term
outcomes of two young patients who underwent TEVAR for blunt thoracic aortic injury with first-generation thoracic
stent grafts. The off-label use of the endograft affected the outcomes: one case of open surgery conversion due to an
aortoesophageal fistula and one case of endovascular relining for a voluminous pseudoaneurysm associated with a type
III endoleak. Long-term follow-up is crucial in TEVAR, especially in case of a first-generation device used in an urgent
setting. (J Vasc Surg Cases and Innovative Techniques 2021;7:16-20.)
Keywords: Thoracic endovascular aortic repair; Thoracic aortic injury; Thoracic aorta; Personalized medicineBlunt thoracic aortic injury (BTAI) is a life-threatening
emergency, usually resulting from a relevant decelera-
tion at the aortic isthmus level, and it is reported that
up to 80% of patients die instantly.1,2
Open surgical repair has been the standard procedure
for BTAI since it was introduced in 1959.3 This surgery con-
sists of thoracotomy, systemic anticoagulation, use of
cardiopulmonary bypass, and aortic cross-clamping. It re-
sults in a high postoperative mortality rate and frequent
major postoperative complications.4
In fact, several dilatative complications have been
described after complex aortic surgery such as aneurysms
and pseudoaneurysms and often a variety of procedures
are needed, but the real fate of these complications is
often only partially known.5,6
In 1997, Kato et al7 were the first to report the use of
stent grafts for BTAI. Over the last two decades, thoracic
endovascular aortic repair (TEVAR) has become the gold
standard treatment in these patients.8
Although TEVAR had been considered as a safe and a
superior alternative to open repair,9 severe complications
may occur, including device-related complications,
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doi.org/10.1016/j.jvscit.2020.08.035and graft infection with aortobronchial or aortopulmo-
nary fistulation.10-12
However, TEVAR long-term results and efficacy remain
unknown, mostly for young patients.
We describe long-term outcomes of two young
patients treated with TEVAR for BTAI with the first-
generation thoracic stent graft. The patients’ consent
for publication was obtained.
CASE 1
A 34-year-old man underwent TEVAR with the EndoFit thoracic
stent-graft system (LeMaitre Vascular, Inc, Burlington, Mass; Fig 1)
due to a grade III (pseudoaneurysm) BTAI at the age of 19 years
in 2002 after a car accident. The patient did not undergo a regu-
lar scheduled follow-up, and 15 years after the first treatment, he
presented with an acute onset of severe back and chest pain, he-
moptysis, and fever. The computed tomography angiography
(CTA) and the esophagogastroduodenoscopy showed a fistula
between the aortic stent graft and the esophagus (Fig 2). The
gastric cavity was full of blood clots. Open late conversion was
highly recommended. Surgery was performed by left thoracot-
omy, with extracorporeal circulation. The stent graft was
explanted, the aorta was reconstructed with a 28-mm gelatin-
sealed Dacron graft (Gelweave; Vascutek Terumo, Renfrewshire,
Scotland; Fig 1, B), and the aortoesophageal fistula was repaired.
The postoperative course was complicated by early reintervention
for hemostasis revision due to a massive bleeding, caused by
laceration of the ascending aorta. At early follow-up, we found
dysphonia and paralysis of the left vocal cord caused by open
repair that required speech therapy cycles and lipofilling surgery
of the vocal cord with partial voice rehabilitation.
CASE 2
The second case that we report is a young man who under-
went TEVAR for grade III BTAI after a motor vehicle accident
at the age of 26 years in 1997. A 100-mm-long stent graft con-
structed from modified Z-stents covered with expanded polyte-
trafluoroethylene graft material was deployed in proximal
landing zone 3.13 The patient did not perform the planned
Fig 1. Volume rendering of thoracic endovascular aortic repair (TEVAR) with the EndoFit thoracic stent-graft
system (A) and volume rendering of aortic reconstruction with a gelatin-sealed Dacron graft (B).
Fig 2. Multiplanar reconstruction showing the aortoesophageal fistula after thoracic endovascular aortic repair
(TEVAR).
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cular procedure, a CTA showed an asymptomatic voluminous
pseudoaneurysm of the post-isthmic thoracic aorta with a
maximum diameter of 60 mm with a type III endoleak (Fig 3).
A proximal relining TEVAR in proximal landing zone 313 with
Conformable Gore TAG Thoracic Endoprosthesis (W. L. Gore
and Associates, Flagstaff, Ariz), using a bilateral femoral percuta-
neous approach, was performed. The procedure was carried outunder three-dimensional fusion imaging in our hybrid room
(Fig 4), with lower costs in terms of X ray and contrast medium
exposure.14 The postoperative computed tomography (CT)
scan showed the complete exclusion of the pseudoaneurysm
dilatation (Fig 5).
The patient was discharged on the third postoperative day.
After 1 year, the patient underwent a CT examination that
showed no signs of endoleak or graft migration.
Fig 3. Volume rendering and multiplanar reconstruction of thoracic endovascular aortic repair (TEVAR) that
shows a type III endoleak.
Fig 4. Relining thoracic endovascular aortic repair (TEVAR)
under three-dimensional fusion imaging.
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Aortic injury is the secondmost frequent cause of death
in cases of blunt traumatic injury.15 TEVAR has an
increasing role in the treatment of BTAI, with a lower
rate of mortality, spinal cord ischemia, and renal failure
with respect to the traditional open surgical repair.
Current Society for Vascular Surgery clinical practice
guidelines recommend the use of TEVAR for grade II-IV
and nonoperative management for grade I BTAI.8In consideration of the severity of the traumatic pa-
thology and the reduced frequency in which it occurs,
data comparing open repair and TEVAR are limited,
and there are no randomized controlled studies
comparing the two interventions. Harky et al9 in their
systematic review and meta-analysis demonstrate a
significant survival rate at 30 days and 1 year with the
use of TEVAR. Indeed, TEVAR quickly became a univer-
sally accepted alternative to conventional open
surgery.16
TEVAR for BTAI is associated with a 7.3% in-hospital
mortality in Vascular Quality Initiative, and independent
risk factors for mortality include age, male gender, renal
impairment, left subclavian artery involvement, and over-
all injury burden.8
In terms of reintervention, in Harsky’s meta-analysis,
there was no difference between TEVAR and open
repair; the reintervention in the TEVAR group was
related to endoleaks, whereas in the open repair cohort,
the main cause of reintervention was bleeding. Howev-
er, there are scarce data regarding the long-term
follow-up.
A rare but extremely serious complication is repre-
sented by the aortobronchial or pulmonary fistula. The
incidence of either fistulizations in the entire cohort after
TEVAR is reported to be approximately 0.56% in the
literature.11,12
In our cases, the patients were very young and, at the
time of treatment, a few cases of TEVAR had been car-
ried out, especially for aortic trauma, as a life-saving
treatment.
Fig 5. Volume rendering and multiplanar reconstruction of postoperative computed tomography (CT).
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BTAI that determined serious complications, especially
in long-term follow-up. Although the devices used in
these patients were off label and implanted at a time
before commercially available, the complications asso-
ciated with these repairs are certainly applicable to
modern devices and highlight the importance of long-
term follow-up. In the majority of cases, patients with
BTAI are young, with a small aortic diameter, and with
focal lesions requiring a very limited aortic coverage,
without the oversizing generally used in the aneurysmal
pathology. Life expectancy in these young patients is
very long, and then the follow-up should be tighter
and longer than other treatments. However, a specific
surveillance program for patients with BTAI treated
with TEVAR has not yet been established. To make
the follow-up more effective and pursued, we suggest
that one way to reduce the exposure of patients to X
rays could be an alternation between the angio-CT ex-
amination and the transesophageal echocardiogram.
We recommend performing the first CTA 1 month after
the procedure and, in the absence of complications, at
12 and 24 months. Then, we propose to alternate a
transesophageal echocardiogram to a CTA every 2 years
lifelong. The patient must be adequately informed of
his condition and of the surgical treatment to which
he has undergone to make himself part of the complex
follow-up process that will inevitably accompany him
throughout his life. In light of these considerations,
the follow-up must be conceived as an integral part of
the treatment that finds its completion only in the
long term.
CONCLUSIONS
TEVAR is the first choice of treatment for traumatic
isthmic rupture. Our reports highlight the need for
continued and tight surveillance of patients after TEVAR,
especially in the case of first-generation devices used inan urgent setting, or in case of young people with a
long-term follow-up expectancy.REFERENCES
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